Luke Nathaniel Walker Zentalis Pharmaceuticals, Inc. (ZNTL) insider trading activity

Luke Nathaniel Walker is Director of Zentalis Pharmaceuticals, Inc.. Currently has a direct ownership of 72,481 shares of ZNTL, which is worth approximately $240,636. The most recent transaction as insider was on May 24, 2024, when has been sold 72,481 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 72.5K

0% 3M change

n/a 12M change

Total Value Held $240,636

Luke Nathaniel Walker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
May 24 2024	BUY Grant, award, or other acquisition	-	72,481 Added 50.0%	72,481 Common Stock

Also insider at

HARP

Harpoon Therapeutics, Inc. Healthcare

Chief Medical Officer

CNTX

Context Therapeutics Inc. Healthcare

Director

LNW